Xponance Inc. Lowers Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Xponance Inc. lessened its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 13.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 27,755 shares of the medical instruments supplier’s stock after selling 4,357 shares during the quarter. Xponance Inc.’s holdings in DENTSPLY SIRONA were worth $691,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XRAY. First Eagle Investment Management LLC grew its position in shares of DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares during the period. Nuance Investments LLC increased its position in shares of DENTSPLY SIRONA by 3.8% in the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after buying an additional 402,329 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of DENTSPLY SIRONA by 21.1% during the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after buying an additional 1,419,503 shares during the period. Cooke & Bieler LP lifted its position in shares of DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after buying an additional 1,046,105 shares in the last quarter. Finally, Generation Investment Management LLP grew its stake in DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after acquiring an additional 1,998,012 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 2.0 %

Shares of NASDAQ:XRAY opened at $27.05 on Monday. DENTSPLY SIRONA Inc. has a 52-week low of $23.58 and a 52-week high of $37.60. The stock has a market cap of $5.48 billion, a P/E ratio of -61.48, a PEG ratio of 1.25 and a beta of 1.00. The business has a fifty day moving average of $25.54 and a two-hundred day moving average of $27.56. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.51 earnings per share. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on XRAY shares. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Barrington Research reiterated an “outperform” rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Needham & Company LLC reissued a “buy” rating and set a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Finally, Evercore ISI reduced their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $33.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.